Our results showed that the Ad-CAIX/Ad-PD-L1 vaccine significantly enhanced the induction and maturation of DCs or DC subsets, promoted the multifunctional CD8+ T-cell responses, and inhibited the growth of tumor growth in mice bearing hCAIX-Renca. This evidence concerns the gene CA9 and neoplasm.